Top Stories from Drug Topics: June 2014
July 1st 2014We all know that electronic prescriptions solved all those script communication problems between prescribers and pharmacists, right? Well, the Cynical Pharmacist dispelled any such myths in his blog “Electronic prescriptions: Return to sender.” It was our most-read story of June.
Patient view of treatment burden critical to health gains in T2DM
June 30th 2014Although intensive glycemic control has been the standard of care for delaying the onset and slowing the progression of microvascular disease, treatment burden and unwanted effects like weight gain, hypoglycemia, and gastrointestinal side effects do affect patients’ quality of life. Patient preferences and their views of treatment burden need to be considered when making decisions about glycemic treatment, according to a report published online for JAMA Internal Medicine.
FDA to host webinar on drug supply chain safety
June 25th 2014On July 1, 2014, FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (CDER SBIA) will host a webinar designed to help manufacturers, repackagers, wholesale distributors, and dispensers identify suspect products.
CDC expert questions statin use for more Americans
June 24th 2014Last November, the American Heart Association (AHA) and the American College of Cardiology (ACC) recommended statin therapy for approximately 33 million more Americans who don’t have cardiovascular disease (CVD), but have an estimated 10-year CV risk of 7.5% or higher.
Groups urging expanded Medicare pharmacy choice
June 13th 2014Pharmacy groups, patient advocates, and many businesses are urging Congress to pass legislation that would allow Medicare beneficiaries to use discounted or preferred copays at independent pharmacies willing to accept the terms of Part D prescription drug plans.